0327 GMT - IHH Healthcare's near-term growth prospects are supported by resilient demand for quality healthcare, improving patient numbers and ongoing capacity expansion, Public Investment Bank says in a note. Growth in its Malaysia business should remain supported by medical tourism and same-day medical procedures, it says. Its Singapore business is expected to recover in 2H as hospital occupancy and margins improve, it adds. Public Investment Bank maintains its rating on IHH at outperform and its target price at 11.43 ringgit. Shares are 1.0% higher at 8.23 ringgit.